The Technical Analyst
Select Language :

Avid Bioservices Inc. [CDMOP]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

Avid Bioservices Inc. is listed at the NASDAQ Exchange

0.04% $25.06

Last updated: 28 Nov 2021 @ 16:57 pm


FUNDAMENTALS
MarketCap: 205.07 mill
EPS: -0.0040
P/E: 0.000
Earnings Date: Jun 30, 2020
SharesOutstanding: 8.18 mill
Avg Daily Volume: 0.0113 mill
RATING 2021-04-21
A+
Strong Buy
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Buy
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
2/203/204/201/212/213/21
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.000 | sector: PE 67.21
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE 0.000 | industry: PE 479.09
DISCOUNTED CASH FLOW VALUE
$28.07
(12.00%) $3.01
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-08-02 Green Nicholas Stewart Sell 18 701 Common Stock, $0.001 par value
2021-07-30 Green Nicholas Stewart Buy 37 500 Common Stock, $0.001 par value
2021-07-30 Green Nicholas Stewart Sell 37 500 Restricted Stock Units
2021-07-12 Ziebell Mark R Sell 5 302 Common Stock, $0.001 par value
2021-07-12 Ziebell Mark R Sell 1 905 Common Stock, $0.001 par value
INSIDER POWER
52.27
Last 100 transactions
Buy: 1 875 744 | Sell: 285 511

Forecast: 14:40 - $25.06

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $25.06
Forecast 2: 14:00 - $25.06
Forecast 3: 14:40 - $25.06
SCORE
-5.30
Sell
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $25.06 (0.04% )
Volume 0.0125 mill
Avg. Vol. 0.0113 mill
% of Avg. Vol 109.94 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock

Last 12 Months

Last 12 months chart data with high, low, open and close for Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock

RSI

Intraday RSI14 chart for Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock
The Live Chart for Avid Bioservices Inc...
Profile picture for
            Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock

CDMOP

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Last 10 Buy Signals
Date Signal @
XRPUSDNov 28 - 11:510.918
XRPUSDNov 28 - 11:440.914
BTCUSDNov 28 - 11:2954 102
DOGEUSDNov 28 - 11:29$0.198
XRPUSDNov 28 - 11:230.920
XRPUSDNov 28 - 11:100.924
XRPUSDNov 28 - 10:590.926
XRPUSDNov 28 - 10:550.928
BTCUSDNov 28 - 10:5354 420
DOGEUSDNov 28 - 10:46$0.201

Stock Peers

Company Price Change
CDMOP25.060.04%
ASLN1.5302.68%
CRBP0.884-3.06%
CTIC2.485.98%
KIN9.250.11%
MNOV3.22-9.80%
OBSV2.240.00%
ORPH3.30-2.94%
SMTI28.65-1.21%
TCDA7.40-3.77%
VTVT1.340-2.19%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.